SRPT Duchenne Drug trial hits 5 year mark, page-46

But where is the evidence that they are doing anything whatsoever about their situation? As pixie pointed out there is a big wide world out there. Europe could have progressed substantially and with an ageing population in Japan and a medical innovation friendly environment traction could have happened there as well. And what signs have we really seen that Prana are calling out this stitch up as you call it? And which USA drug are you talking about that would be the immediate competition for PBT2 that would prompt a massive investment in getting FDA to hold us up? If it's clear what that drug is then why isn't Prana calling it out? I keep hearing conspiracy but I can't see the clear culprit here.